PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Malnati, M.S.* ; Heltai, S.* ; Cosma, A. ; Reitmeir, P. ; Allgayer, S. ; Glashoff, R.H.* ; Liebrich, W.* ; Vardas, E.* ; Imami, N.* ; Westrop, S.* ; Nozza, S.* ; Tambussi, G.* ; Buttò, S.* ; Fanales-Belasio, E.* ; Ensoli, B.* ; Ensoli, F.* ; Tripiciano, A.* ; Fortis, C.* ; Lusso, P.* ; Poli, G.* ; Erfle, V. ; Holmes, H.*

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses.

J. Immunol. Methods 375, 46-56 (2012)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Delineation of the immune correlates of protection in natural infection or after vaccination is a mandatory step for vaccine development. Although the most recent techniques allow a sensitive and specific detection of the cellular immune response, a consensus on the best strategy to assess their magnitude and breadth is yet to be reached. Within the AIDS Vaccine Integrated Project (AVIP http://www.avip-eu.org) we developed an antigen scanning strategy combining the empirical-based approach of overlapping peptides with a vast array of database information. This new system, termed Variable Overlapping Peptide Scanning Design (VOPSD), was used for preparing two peptide sets encompassing the candidate HIV-1 vaccine antigens Tat and Nef. Validation of the VOPSD strategy was obtained by direct comparison with 15mer or 20mer peptide sets in a trial involving six laboratories of the AVIP consortium. Cross-reactive background responses were measured in 80 HIV seronegative donors (HIV-), while sensitivity and magnitude of Tat and Nef-specific T-cell responses were assessed on 90 HIV+ individuals. In HIV-, VOPSD peptides generated background responses comparable with those of the standard sets. In HIV-1+ individuals the VOPSD pools showed a higher sensitivity in detecting individual responses (Tat VOPSD vs. Tat 15mers or 20mers: p≤0.01) as well as in generating stronger responses (Nef VOPSD vs. Nef 20mers: p<0.001) than standard sets, enhancing both CD4 and CD8 T-cell responses. Moreover, this peptide design allowed a marked reduction of the peptides number, representing a powerful tool for investigating novel HIV-1 candidate vaccine antigens in cohorts of HIV-seronegative and seropositive individuals.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.340
0.885
4
7
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Peptide; Tat; Nef; ELISpot; HIV-1; Vaccine
Language english
Publication Year 2012
Prepublished in Year 2011
HGF-reported in Year 2011
ISSN (print) / ISBN 0022-1759
e-ISSN 1872-7905
Journal Journal of Immunological Methods
Quellenangaben Volume: 375, Issue: 1-2, Pages: 46-56 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
Institute(s) Institute of Molecular Immunology (IMI)
Institute of Health Economics and Health Care Management (IGM)
Institute of Virology (VIRO)
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30202 - Environmental Health
Research field(s) Immune Response and Infection
Genetics and Epidemiology
PSP Element(s) G-501790-002
G-501790-001
G-501790-003
G-505300-002
PubMed ID 21963950
DOI 10.1016/j.jim.2011.09.005
Scopus ID 84855346712
Erfassungsdatum 2011-12-31
[➜Report correction]